ALFA BIOTECH S.P.A. – Trademark Portfolio

Entity Type: 03

ALFA BIOTECH S.P.A. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. The owner is based in 0040 Pomezia (Roma).

Via Castegnetta, 7

0040 Pomezia (Roma) , IT

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SIPARIO
SIPARIO
Cancelled 1999
AURAFLEX
AURAFLEX
Cancelled 1998

Trademark Classifications

ALFA BIOTECH S.P.A.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does ALFA BIOTECH S.P.A. have?

ALFA BIOTECH S.P.A. has 2 U.S. trademarks filed with the USPTO.

What trademark classes does ALFA BIOTECH S.P.A. file in?

ALFA BIOTECH S.P.A. files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 16 (Paper Goods), Class 5 (Pharmaceuticals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What is ALFA BIOTECH S.P.A.'s trademark registration success rate?

ALFA BIOTECH S.P.A. has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.